IDEAYA Biosciences, Inc. IDYA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $157.52M+21.2% | $112.83M+33.7% | $298.93M-25.3% | $114.65M-37.4% | $130M+20.0% | ||
| $513.68M-8.7% | $526.56M-11.0% | $487.97M-6.1% | $555.09M+7.0% | $562.51M-4.7% | ||
| $1.28M+59.1% | $1.02M+26.1% | $805K-11.6% | $805K-11.6% | $805K+6.3% | ||
| $18.35M+19.4% | $21.37M+59.5% | $15.76M+29.6% | $15.86M+37.7% | $15.36M+45.4% | ||
| $6.56M— | $5.97M— | —— | —— | —— | ||
| $696.11M-1.7% | $666.73M-3.3% | $802.66M-13.9% | $685.6M-3.9% | $707.87M-0.2% | ||
| $8.63M-2.7% | $8.22M-8.4% | $8.17M-0.8% | $8.82M+23.8% | $8.87M+28.4% | ||
| $22.61M-7.4% | $23.07M+22.9% | $23.54M+28.1% | $23.91M+1,732% | $24.43M+1,272% | ||
| $1.03B-6.4% | $1.11B-1.3% | $1.19B-4.4% | $1.04B+6.9% | $1.1B+14.5% | ||
| $20.74M+17.6% | $17.58M+14.0% | $18.43M+46.7% | $17.27M+8.7% | $17.63M+180% | ||
| $43.75M+32.9% | $40.89M+34.7% | $45.26M+61.1% | $37.75M+55.7% | $32.91M+87.8% | ||
| —— | —— | $490K— | —— | —— | ||
| $350K+13.6% | $339K+13.8% | $328K— | $318K-47.5% | $308K-73.2% | ||
| $64.83M+27.5% | $58.82M+27.7% | $64.51M+58.7% | $55.34M+35.8% | $50.85M+104% | ||
| $28.25M+10.1% | $27.58M+46.1% | $26.92M+43.2% | $26.28M+1,981% | $25.66M+1,943% | ||
| $28.6M+10.1% | $27.91M+45.6% | $27.25M+45.0% | $26.6M+1,323% | $25.97M+979% | ||
| $93.08M+21.7% | $86.39M+33.0% | $93.1M+56.6% | $81.62M+94.3% | $76.51M+192% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K+12.5% | $9K+28.6% | ||
| $1.77B+3.2% | $1.76B+4.5% | $1.74B+4.4% | $1.73B+26.0% | $1.72B+29.7% | ||
| -$835.08M-20.2% | -$736.54M-18.3% | -$653.27M-32.6% | -$772.51M-75.3% | -$695.02M-79.2% | ||
| -$494K-131% | $2.27M+179% | $2.05M-46.5% | $1.52M+207% | $1.59M+272% | ||
| $937.27M-8.5% | $1.02B-3.4% | $1.09B-7.5% | $959.65M+3.0% | $1.02B+9.5% | ||
| $1.03B-6.4% | $1.11B-1.3% | $1.19B-4.4% | $1.04B+6.9% | $1.1B+14.5% | ||
| $513.68M-8.7% | $526.56M-11.0% | $487.97M-6.1% | $555.09M+7.0% | $562.51M-4.7% | ||
| $22.61M-7.4% | $23.07M+22.9% | $23.54M+28.1% | $23.91M+1,732% | $24.43M+1,272% | ||
| $22.61M-7.4% | $23.07M+22.9% | $23.54M+28.1% | $23.91M+1,732% | $24.43M+1,272% | ||
| $22.61M-7.4% | $23.07M+22.9% | $23.54M+28.1% | $23.91M+1,732% | $24.43M+1,272% | ||
| $43.75M+32.9% | $40.89M+34.7% | $45.26M+61.1% | $37.75M+55.7% | $32.91M+87.8% | ||
| $43.75M+32.9% | $40.89M+34.7% | $45.26M+61.1% | $37.75M+55.7% | $32.91M+87.8% | ||
| $28.6M+10.1% | $27.91M+45.6% | $27.25M+45.0% | $26.6M+1,323% | $25.97M+979% | ||
| $1.77B+3.2% | $1.76B+4.5% | $1.74B+4.4% | $1.73B+26.0% | $1.72B+29.7% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K+12.5% | $9K+28.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are IDEAYA Biosciences, Inc.'s total assets?
- IDEAYA Biosciences, Inc. (IDYA) holds $1.0B in total assets, down 6.4% year over year.
- How much debt does IDEAYA Biosciences, Inc. have?
- IDEAYA Biosciences, Inc. carries $28.6M in total debt against $937.3M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does IDEAYA Biosciences, Inc. have?
- IDEAYA Biosciences, Inc. holds $157.5M in cash and equivalents.
- Can IDEAYA Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 10.74 — current assets exceed current liabilities.
- Where does IDEAYA Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
